Alacris Theranostics Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$955K
- Investors
-
1
Alacris Theranostics General Information
Description
Operator of a biotech company intended to develop precision immuno-oncology treatments. The company is engaged in developing cancer immunotherapies to fight multiple cancer types using Comprehensive Molecular Tumor Analysis, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.
Contact Information
Website
www.alacris.deCorporate Office
- Max-Planck-Straße 3
- 12489 Berlin
- Germany
Corporate Office
- Max-Planck-Straße 3
- 12489 Berlin
- Germany
Alacris Theranostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Equity Crowdfunding | 11-Sep-2020 | $955K | Completed | Generating Revenue | ||
| 1. Corporate | 11-Jan-2011 | Completed | Generating Revenue |
Alacris Theranostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alacris Theranostics Patents
Alacris Theranostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3296905-A1 | Method for identifying new markers | Active | 15-Sep-2016 | ||
| EP-3296905-B1 | Method for identifying new markers | Active | 15-Sep-2016 | ||
| EP-3296905-C0 | Method for identifying new markers | Active | 15-Sep-2016 | ||
| EP-2883963-A1 | Method for generating of oligonucleotide arrays using in situ block synthesis approach | Inactive | 16-Dec-2013 | ||
| EP-3083984-A1 | Method for generating of oligonucleotide arrays using in situ block synthesis approach | Inactive | 16-Dec-2013 | C12Q1/6837 |
Alacris Theranostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alacris Theranostics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Qiagen | Corporation | Minority |
Alacris Theranostics FAQs
-
When was Alacris Theranostics founded?
Alacris Theranostics was founded in 2008.
-
Where is Alacris Theranostics headquartered?
Alacris Theranostics is headquartered in Berlin, Germany.
-
What is the size of Alacris Theranostics?
Alacris Theranostics has 13 total employees.
-
What industry is Alacris Theranostics in?
Alacris Theranostics’s primary industry is Discovery Tools (Healthcare).
-
Is Alacris Theranostics a private or public company?
Alacris Theranostics is a Private company.
-
What is Alacris Theranostics’s current revenue?
The current revenue for Alacris Theranostics is .
-
How much funding has Alacris Theranostics raised over time?
Alacris Theranostics has raised $955K.
-
Who are Alacris Theranostics’s investors?
Qiagen has invested in Alacris Theranostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
